Researchers are expressing optimism that gene therapy can treat a wide range of eye diseases, including some that currently have no treatments. Only one gene therapy has been approved by the US Food and Drug Administration (FDA) so far, and…
Read More
Aflibercept Won’t Help Vision in Early Diabetic Retinopathy
Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and proliferative diabetic retinopathy, however, said Adam R. Glassman, MS,…
Read More